Clindamycin Hydrochloride Capsule
Product Images NDC 67296-0940

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clindamycin Hydrochloride (NDC 67296-0940). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label-principal Display Panel (150 mg (100 Capsules Bottle))

Package Label-principal Display Panel (150 mg (100 Capsules Bottle))
Product Description: This is a prescription-only medication known as Clindamycin Hydrochloride Capsules. Each bottle contains 100 capsules manufactured by Aurobindo Pharma USA, Inc. The capsules are equivalent to 150 mg of Clindamycin hydrochloride USP. The usual dosage of this medication is 150 mg taken four times daily. Proper storage of this medication requires keeping it at a temperature between 20°C to 25°C (68°F to 77°F), with excursions allowed between 15°C to 30°C (59°F to 86°F). The pharmacist should dispense this medication in a light container with a child-resistant closure. The medication is distributed by Aurobindo Pharma USA, Inc., located at 279 Princeton-Hightstown Road, East Windsor, NJ 08520. It is manufactured in India under the code TS/DRUGS/10/1093.*
FDA Label Image

Package Label-principal Display Panel (300 mg (100 Capsules Bottle))

Package Label-principal Display Panel (300 mg (100 Capsules Bottle))
FDA Label Image

Chemical Structure (Clindamycin Str)

Chemical Structure (Clindamycin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.